Résultats de la recherche

  • Flux RSS
(1 - 20 of 30)

Pages

Valeur diagnostique des biomarqueurs Alzheimer du liquide cérébrospinal dans la maladie à corps de Lewy
Diagnostic value of cerebro-spinal fluid biomarkers in dementia with lewy bodies
Diagnostic value of cerebrospinal fluid alpha-synuclein in dementia with Lewy body
Sarcoidosis presenting as late-onset dementia: are cerebrospinal fluid biomarkers analyses helpful?
Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies
Do we know how to diagnose epilepsy early in Alzheimer's disease?
Adenosine and Alzheimer’s Disease : A Possible Epigenetic Link
Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer's disease patients
Detection of histone acetylation levels in the dorsal hippocampus reveals early tagging on specific residues of H2B and H4 histones in response to learning
Epileptic Prodromal Alzheimer’s Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer’s Disease to an Epileptic Variant?
Acetyltransferases (HATs) as targets for neurological therapeutics
CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies
Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice
Late environmental enrichment housing conditions are associated with increased HAT activity and acetylated chromatin structure at specific enhancers in brain derived neurotrophic factor promoter I in the hippocampus of aged rats showing improved memory
Role of histone acetylation in memorization processes: implication in Alzheimer’s patients
Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer’s disease at the prodromal stage
Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF biomarkers..

Pages

Islandora displays